EnClear Therapies
At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business using our CSF Health Platform to create a pipeline of significant near-term, patient focused, opportunities. Launching into neuro-oncology, while leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.
Company details
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Medical Monitoring
- Market Focus:
- Nationally (across the country)
About Us
Our mission is to extend the lives of patients with CNS-related disease.
Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation therapeutics.
Our strategy is two-fold:
- Lead with neuro-oncology and help patients with Leptomeningeal Carcinomatosis.
- Leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.
Enclear Team
Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.
Partners & Collaborators
At EnClear, we are uniquely positioned to partner across traditional and novel drug modalities. We are looking for new partnerships and technologies that will benefit from patient optimized dosing across the central nervous system. We seek partners and collaborators looking to improve patient outcomes through better delivery. We are interested in building relationships with institutional and strategic investors, as well as pre-clinical through commercial stage pharmaceutical companies.